Issue 20, 2006

Conformational analogues of Oxamflatin as histone deacetylase inhibitors

Abstract

Conformational analogues of the hydroxamic acid Oxamflatin 1—compounds 3a, 3b and 4—have been synthesised to enable evaluation of the impact of varying the linking section on histone deacetylase inhibition. Preliminary testing indicates treatment of leukaemia cells with each of the analogues leads to significant inhibition of histone deacetylase and reduction in cell growth and proliferation.

Graphical abstract: Conformational analogues of Oxamflatin as histone deacetylase inhibitors

Article information

Article type
Paper
Submitted
09 Jun 2006
Accepted
18 Jul 2006
First published
31 Aug 2006

Org. Biomol. Chem., 2006,4, 3778-3784

Conformational analogues of Oxamflatin as histone deacetylase inhibitors

A. E. Dear, H. B. Liu, P. A. Mayes and P. Perlmutter, Org. Biomol. Chem., 2006, 4, 3778 DOI: 10.1039/B608213K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements